Kunpo, South Korea

Hye-Yeon Hwang

This inventor holds 1 USPTO granted patent. Top assignee: Pangen Biotech Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hye-Yeon Hwang. Retrieved from https://idiyas.com/inventor/hye-yeon-hwang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hye-Yeon Hwang: Innovator in Mammalian Expression Vectors

Introduction

Hye-Yeon Hwang is a prominent inventor based in Kunpo, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of expression vectors for animal cells. Her work focuses on enhancing the efficiency of recombinant protein expression.

Latest Patents

Hye-Yeon Hwang holds a patent for an expression vector that incorporates the nuclear matrix attachment region of human interferon beta. This invention, which includes vectors such as pPGM-1, pPGM-2, and pPGM-3, allows for position-independent expression of foreign genes. As a result, it increases the frequency of colonies that effectively express recombinant proteins.

Career Highlights

Hye-Yeon Hwang is currently associated with Pangen Biotech Inc., where she continues to advance her research in biotechnology. Her innovative approaches have positioned her as a key figure in her field.

Collaborations

Some of her notable coworkers include Jeong Do Kim and Dong-jun Kim, who contribute to her research endeavors.

Conclusion

Hye-Yeon Hwang's work in developing mammalian expression vectors represents a significant advancement in biotechnology. Her contributions are paving the way for more efficient protein expression techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…